Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Dec;52(6):901–907. doi: 10.1038/bjc.1985.275

Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.

R P Gallagher, J M Elwood, G B Hill, A J Coldman, W J Threlfall, J J Spinelli
PMCID: PMC1977278  PMID: 4074642

Abstract

A study of 361 female melanoma patients and age matched controls was conducted in the four western provinces of Canada. Analysis of reproductive factors showed a significant negative association between number of livebirths and risk of melanoma. The relationship persisted for superficial spreading melanomas after adjustment for host pigmentation factors, freckling, and educational status. An inverse association between bilateral oophorectomy and risk of superficial spreading melanoma was also seen. No association was found between risk of melanoma and age at first birth, age at menarche and age at natural menopause. No association was found between risk of superficial spreading or nodular melanoma and use of either oral contraceptives or menopausal oestrogens.

Full text

PDF
901

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam S. A., Sheaves J. K., Wright N. H., Mosser G., Harris R. W., Vessey M. P. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer. 1981 Jul;44(1):45–50. doi: 10.1038/bjc.1981.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bain C., Hennekens C. H., Speizer F. E., Rosner B., Willett W., Belanger C. Oral contraceptive use and malignant melanoma. J Natl Cancer Inst. 1982 Apr;68(4):537–539. [PubMed] [Google Scholar]
  3. Beral V., Evans S., Shaw H., Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer. 1984 Nov;50(5):681–685. doi: 10.1038/bjc.1984.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beral V., Ramcharan S., Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blot W. J. Changing patterns of breast cancer among American women. Am J Public Health. 1980 Aug;70(8):832–835. doi: 10.2105/ajph.70.8.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brinton L. A., Williams R. R., Hoover R. N., Stegens N. L., Feinleib M., Fraumeni J. F., Jr Breast cancer risk factors among screening program participants. J Natl Cancer Inst. 1979 Jan;62(1):37–44. [PubMed] [Google Scholar]
  7. Creagan E. T., Ingle J. N., Woods J. E., Pritchard D. J., Jiang N. S. Estrogen receptors in patients with malignant melanoma. Cancer. 1980 Oct 15;46(8):1785–1786. doi: 10.1002/1097-0142(19801015)46:8<1785::aid-cncr2820460815>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  8. Elwood J. M., Coldman A. J. Previous pregnancy and melanoma prognosis. Lancet. 1978 Nov 4;2(8097):1000–1001. doi: 10.1016/s0140-6736(78)92574-6. [DOI] [PubMed] [Google Scholar]
  9. Elwood J. M., Gallagher R. P., Hill G. B., Spinelli J. J., Pearson J. C., Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J (Clin Res Ed) 1984 Jan 14;288(6411):99–102. doi: 10.1136/bmj.288.6411.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feinleib M. Breast cancer and artificial menopause: a cohort study. J Natl Cancer Inst. 1968 Aug;41(2):315–329. [PubMed] [Google Scholar]
  11. Fisher R. I., Neifeld J. P., Lippman M. E. Oestrogen receptors in human malignant melanoma. Lancet. 1976 Aug 14;2(7981):337–339. doi: 10.1016/s0140-6736(76)92592-7. [DOI] [PubMed] [Google Scholar]
  12. Helmrich S. P., Rosenberg L., Kaufman D. W., Miller D. R., Schottenfeld D., Stolley P. D., Shapiro S. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst. 1984 Mar;72(3):617–620. [PubMed] [Google Scholar]
  13. Hersey P., Morgan G., Stone D. E., McCarthy W. H., Milton G. W. Previous pregnancy as a protective factor against death from melanoma. Lancet. 1977 Feb 26;1(8009):451–452. doi: 10.1016/s0140-6736(77)91943-2. [DOI] [PubMed] [Google Scholar]
  14. Hildreth N. G., Kelsey J. L., LiVolsi V. A., Fischer D. B., Holford T. R., Mostow E. D., Schwartz P. E., White C. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol. 1981 Sep;114(3):398–405. doi: 10.1093/oxfordjournals.aje.a113207. [DOI] [PubMed] [Google Scholar]
  15. Holly E. A., Weiss N. S., Liff J. M. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst. 1983 May;70(5):827–831. [PubMed] [Google Scholar]
  16. Holman C. D., Armstrong B. K., Heenan P. J. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer. 1984 Nov;50(5):673–680. doi: 10.1038/bjc.1984.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kelsey J. L., Fischer D. B., Holford T. R., LiVoisi V. A., Mostow E. D., Goldenberg I. S., White C. Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst. 1981 Aug;67(2):327–333. [PubMed] [Google Scholar]
  18. Kelsey J. L., LiVolsi V. A., Holford T. R., Fischer D. B., Mostow E. D., Schwartz P. E., O'Connor T., White C. A case-control study of cancer of the endometrium. Am J Epidemiol. 1982 Aug;116(2):333–342. doi: 10.1093/oxfordjournals.aje.a113417. [DOI] [PubMed] [Google Scholar]
  19. Lee J. A., Hill G. B. Marriage and fatal malignant melanoma in females. Am J Epidemiol. 1970 Jan;91(1):48–51. doi: 10.1093/oxfordjournals.aje.a121111. [DOI] [PubMed] [Google Scholar]
  20. MacMahon B., Cole P., Lin T. M., Lowe C. R., Mirra A. P., Ravnihar B., Salber E. J., Valaoras V. G., Yuasa S. Age at first birth and breast cancer risk. Bull World Health Organ. 1970;43(2):209–221. [PMC free article] [PubMed] [Google Scholar]
  21. Miller A. B., Barclay T. H., Choi N. W., Grace M. G., Wall C., Plante M., Howe G. R., Cinader B., Davis F. G. A study of cancer, parity and age at first pregnancy. J Chronic Dis. 1980;33(10):595–605. doi: 10.1016/0021-9681(80)90002-8. [DOI] [PubMed] [Google Scholar]
  22. Posey L. E., Morgan L. R., Jr, Beazley R. M., Lanasa J., Torres J., Krementz E. D., Carter R. D., Sutherland C., Hawley W. Estrogen receptors. JAMA. 1977 Dec 12;238(24):2599–2599. doi: 10.1001/jama.1977.03280250025010. [DOI] [PubMed] [Google Scholar]
  23. Schoenberg B. S., Christine B. W. Malignant melanoma associated with breast cancer. South Med J. 1980 Nov;73(11):1493–1497. doi: 10.1097/00007611-198011000-00023. [DOI] [PubMed] [Google Scholar]
  24. Shaw H. M., Milton G. W., Farago G., McCarthy W. H. Endocrine influences on survival from malignant melanoma. Cancer. 1978 Aug;42(2):669–677. doi: 10.1002/1097-0142(197808)42:2<669::aid-cncr2820420238>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  25. Weiss N. S., Flannery J. T. The relationship of marital status to survival from melanoma. Cancer. 1978 Jul;42(1):296–298. doi: 10.1002/1097-0142(197807)42:1<296::aid-cncr2820420144>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES